← Back
$IOVA All transactions

IOVANCE BIOTHERAPEUTICS, INC.

A

$ Value

$0

Shares

300,000

Price

$0

Filed

Aug 8

Insider

Name

Roche Corleen M.

Title

Chief Financial Officer

CIK

0001857905

Roles

Officer

Transaction Details

Transaction Date

2025-08-06

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

300,000

Footnotes

Provided the Reporting Person is still employed with the Issuer on the following dates, the restricted stock units ("RSUs") and options are each exercisable as follows: (i) RSUs and options for the purchase of one-third of such shares shall vest on the one-year anniversary of the date of grant; and (ii) the remaining RSUs and options shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant. | Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Filing Info

Accession No.

0001104659-25-075687

Form Type

4

Issuer CIK

0001425205

Roche Corleen M.'s History

Date Ticker Type Value
2026-03-09 IOVA A $0
2025-08-06 IOVA A $0
2025-08-06 IOVA A $0

Other Insiders at IOVA (90d)

Insider Bought Sold Last
BILINSKY IGOR
Chief Operating Officer
2026-03-09
Vogt Frederick G
Interim CEO & General Counsel
2026-03-09
GRAF FINCKENSTEIN FRIEDRICH
Chief Medical Officer
2026-03-09
Roche Corleen M.
Chief Financial Officer
2026-03-09
Puri Raj K.
Chief Regulatory Officer
2026-03-09
Kirby Daniel Gordon
Chief Commercial Officer
2026-03-09